Commentary to provide context and explain significance of research is sometimes just as important as the research itself. That’s why our experts make it a priority to provide you with helpful content distilled from the many years of experience our team has accumulated. The Drug Development Insights blog contains overviews and deep dives into the drug metabolism and pharmacokinetics topics you care about—regulatory expectations, risk assessment, safety considerations, scientific innovation, study design elements, interpretation of results, and more. Explore our entries chronologically or by category to get insight into the many pieces of your drug’s development.
Drug Development Blog
The FDA has requested follow-up data… how do I fill in the gaps?
- Regulatory Guidance
- October 9, 2019
- Madison Esely-Kohlman
Because each new drug is unique in characteristics, such as chemical structure, mechanism of action, and physicochemical properties, there can...
Why You Need QWBA for Human Radiolabeled ADME Studies
- Regulatory Guidance
- October 4, 2019
- Satoshi Ito
A quantitative whole body autoradiography (QWBA) study provides data required for Human Radiolabeled ADME Studies1. Quantitative whole body autoradiography (QWBA) is an in...
XenoTech Named Best In Vitro Drug CRO 2019
- Updated Offerings
- September 19, 2019
- Michael Millhollen
XenoTech has been named the Best In Vitro Drug CRO in the 2019 Healthcare & Pharmaceutical Awards. From the release:...
How to Choose the Right Test Systems for Your DMPK Studies
- Test Systems & Methods
- September 12, 2019
- Dr. Chris Bohl, Madison Esely-Kohlman
Test systems for DMPK in vitro studies are part of the very foundation of our company. Our labs were borne of...
XenoTech Named a 2019 Top-Performing Provider on Science Exchange
- Updated Offerings
- September 4, 2019
- Michael Millhollen
Science Exchange stated, “Discovery research programs at growing biotech companies are demanding—R&D leaders must balance the need to innovate with...
Cypex Adds Recombinant UGTs
- Updated Offerings
- September 3, 2019
- Madison Esely-Kohlman
Recombinant enzymes represent a useful test system for studies requiring extra high levels of catalytic activity. Due to high customer demand, Cypex has...
Consultancy Expansion
- Consultancy
- August 20, 2019
- Madison Esely-Kohlman
We are proud to house some of the brightest minds in this field who have seen “the weird stuff” when...
Can CYP3A4 Induction Predict P-glycoprotein Induction in DDI Studies?
- Enzyme Induction
- August 20, 2019
- Shanté Jackson, Madison Esely-Kohlman
Generally, a drug’s effects on enzyme and transporter activity are examined independently in a drug development program, but what if...
Reduced Pricing for In Vitro Transporter Studies
- Updated Offerings
- August 20, 2019
- Madison Esely-Kohlman
We’re pleased to announce that our scientists’ ongoing dedication to enhancing our processes and discovering new efficiencies without sacrificing quality...
XenoTech Named Best for Drug Candidate Evaluations 2019, Leading Providers of Pharmaceuticals Safety Testing
- Updated Offerings
- August 12, 2019
- Michael Millhollen
XenoTech has been named the Best for Drug Candidate Evaluations 2019 as well as in the Leading Providers of Pharmaceuticals...
Subscribe to our Newsletter
Stay up to date with our news, events and research
Do you have a question or a request for upcoming blog content?
We love to get your feedback